[EN] ORAL COMPLEMENT FACTOR D INHIBITORS<br/>[FR] INHIBITEURS ORAUX DU FACTEUR D DU COMPLÉMENT
申请人:BIOCRYST PHARM INC
公开号:WO2021072198A1
公开(公告)日:2021-04-15
Disclosed are compounds of formula (I), and pharmaceutically acceptable salts thereof, which are inhibitors of the complement system. Also provided are pharmaceutical compositions comprising such a compound, and methods of using the compounds and compositions in the treatment or prevention of a disease or condition characterized by aberrant complement system activity.
揭示了式(I)的化合物及其药学上可接受的盐,这些化合物是裂解系统的抑制剂。还提供了包含这种化合物的药物组合物,以及使用这些化合物和组合物治疗或预防由异常裂解系统活性特征的疾病或状况的方法。